Helix BioMedix, Inc., a developer of bioactive peptides, today announced its strategic milestones for 2006, which management recently presented to the company's Board of Directors. The company believes that these milestones will be an important step in transitioning the company from primarily a research and development organization to a revenue generating commercial entity. "With this announcement, we are outlining a comprehensive program to build the company for the long-term, with a plan to increase revenues on the consumer side of our business as well as prepare to take advantage of the significant longer-term opportunity on the pharmaceutical side," said R. Stephen Beatty, President and Chief Executive Officer of Helix BioMedix. \

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/01-23-2006/0004265287&EDATE=)